RenovoRx (RNXT)
NASDAQ:RNXT
Want to see RNXT full AI Analyst Report?
Total Valuation
RenovoRx has a market cap or net worth of $39.71M. The enterprise value is $20.53M.
Market Cap$39.71M
Enterprise Value$20.53M
Share Statistics
RenovoRx has 45,052,708 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding45,052,708
Owned by Insiders3.34%
Owned by Institutions12.96%
Financial Efficiency
RenovoRx’s return on equity (ROE) is -2.06 and return on invested capital (ROIC) is -203.98%.
Return on Equity (ROE)-2.06
Return on Assets (ROA)-1.38
Return on Invested Capital (ROIC)-203.98%
Return on Capital Employed (ROCE)-2.04
Revenue Per Employee112.30K
Profits Per Employee-1.12M
Employee Count10
Asset Turnover0.14
Inventory Turnover1.73
Valuation Ratios
The current PE Ratio of RenovoRx is ―. RenovoRx’s PEG ratio is 0.20.
PE Ratio―
PS Ratio26.43
PB Ratio5.47
Price to Fair Value5.47
Price to FCF-2.70
Price to Operating Cash Flow-2.97
PEG Ratio0.20
Income Statement
In the last 12 months, RenovoRx had revenue of 1.12M and earned -11.17M in profits. Earnings per share was -0.32.
Revenue1.12M
Gross Profit796.00K
Operating Income-12.51M
Pretax Income-11.17M
Net Income-11.17M
EBITDA-12.51M
Earnings Per Share (EPS)-0.32
Cash Flow
In the last 12 months, operating cash flow was -11.30M and capital expenditures 0.00, giving a free cash flow of -11.30M billion.
Operating Cash Flow-11.30M
Free Cash Flow-11.30M
Free Cash Flow per Share-0.25
Dividends & Yields
RenovoRx pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.76
52-Week Price Change-25.97%
50-Day Moving Average0.94
200-Day Moving Average1.00
Relative Strength Index (RSI)50.38
Average Volume (3m)288.82K
Important Dates
RenovoRx upcoming earnings date is Aug 13, 2026, After Close (Confirmed).
Last Earnings DateMay 14, 2026
Next Earnings DateAug 13, 2026
Ex-Dividend Date―
Financial Position
RenovoRx as a current ratio of 4.02, with Debt / Equity ratio of 0.69%
Current Ratio4.02
Quick Ratio3.93
Debt to Market Cap<0.01
Net Debt to EBITDA0.55
Interest Coverage Ratio0.00
Taxes
In the past 12 months, RenovoRx has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
RenovoRx EV to EBITDA ratio is -1.82, with an EV/FCF ratio of -2.07.
EV to Sales20.27
EV to EBITDA-1.82
EV to Free Cash Flow-2.07
EV to Operating Cash Flow-2.07
Balance Sheet
RenovoRx has $12.36M in cash and marketable securities with $78.00K in debt, giving a net cash position of $12.28M billion.
Cash & Marketable Securities$12.36M
Total Debt$78.00K
Net Cash$12.28M
Net Cash Per Share$0.27
Tangible Book Value Per Share$0.15
Margins
Gross margin is 78.71%, with operating margin of -1113.98%, and net profit margin of -994.48%.
Gross Margin78.71%
Operating Margin-1113.98%
Pretax Margin-994.48%
Net Profit Margin-994.48%
EBITDA Margin-1113.98%
EBIT Margin-1114.07%
Analyst Forecast
The average price target for RenovoRx is $6.88, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$6.88
Price Target Upside587.50% Upside
Analyst ConsensusStrong Buy
Analyst Count4
Revenue Growth Forecast520.42%
EPS Growth Forecast16.12%